相关实验视频
Updated: Jan 11, 2026

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.9K
质子抑制剂诱导的血小板缺血:对病例报告的系统文献分析
1Rehabilitation Pharmacy Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, 100144, PR China.
Open medicine (Warsaw, Poland)
|November 11, 2025
概括
质子抑制剂 (PPI) 诱导的血小板缺血是一种罕见的药物不良反应. 意识和迅速戒药对于管理这种情况至关重要,在大多数情况下导致症状改善.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 质子抑制剂 (PPI) 是一种被广泛处方的药物.
- 血小板缺血是一种已知的,尽管不常见的,与PPI使用相关的不良影响.
研究的目的:
- 调查由质子抑制剂 (PPI) 诱导的血小板缺血的临床特征.
- 分析已发表的病例报告,以了解PPI诱导的血小板缺血的特征.
主要方法:
- 在多个数据库 (PubMed,科学网,Scopus等) 中进行系统的文献搜索. 在2024年8月之前.
- 包括16篇出版物,详细介绍了18例PPI相关的血小板缺血.
- 提取和分析临床数据,包括患者人口统计,PPI使用,不良反应和结果.
主要成果:
- 确定了18例病例,平均年龄为62岁.
- 潘托普拉是最常见的PPI (11例),其次是兰索普拉 (4例).
- 症状的中位数发生在PPI开始后3天;在PPI停止和治疗后,11名患者康复.
结论:
- 由PPI诱导的血小板缺血是一种罕见但显著的不良事件.
- 临床医生应在使用PPI的患者中保持高血小板缺血的怀疑指数.
- 建议立即停止使用PPI,并采取适当的干预措施来管理.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
833
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
833
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Peptic Ulcer Disease IV: Management
419
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
419
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K

